Literature DB >> 975042

Selective lethal effect of supranormal temperatures on human neoplastic cells.

B C Giovanella, J S Stehlin, A C Morgan.   

Abstract

The effects of supranormal temperatures upon normal human cells (derived from normal adult and embryonal tissues) and neoplastic human cells (derived from biopsies of malignant tumors) have been quantitatively studied in tissue culture. Melanoma cells have been compared with melanocytes derived from fetal uveas. Colon carcinoma cells have been compared with embryonal intestinal epithelial cells. Malignant neuroepithelial cells derived from a teratocarcinoma of the ovary have been compared with neuroepithelial cells derived from fetal brain. Fibrosarcoma cells have been compared with normal adult fibroblasts. All cells defined as neoplastic have produced malignant tumors when injected into nude thymus-deficient mice at doses of 1 X 10(7) cells or less. Exposure to temperatures of 42.5-43.0 degrees for 4 to 8 hr has been shown to have significantly greater lethal effect on the tumor cells than on the nonneoplastic cells.

Entities:  

Mesh:

Year:  1976        PMID: 975042

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

Review 1.  Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer.

Authors:  Renee A Cowan; Roisin E O'Cearbhaill; Oliver Zivanovic; Dennis S Chi
Journal:  Int J Hyperthermia       Date:  2017-08       Impact factor: 3.914

2.  Intraperitoneal approach to regional hyperthermia--possible anticancer applications.

Authors:  G V Smith; R MacMillan; J Stribling
Journal:  World J Surg       Date:  1983-11       Impact factor: 3.352

3.  Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer.

Authors:  Claudio Zanon; Renzo Clara; Isabella Chiappino; Massimiliano Bortolini; Silvia Cornaglia; Paolo Simone; Francesco Bruno; Leonarda De Riu; Mario Airoldi; Fulvia Pedani
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

4.  Heat sensitivity and membrane properties of metastasizing and non-metastasizing rat mammary tumors.

Authors:  M B Yatvin; J W Vorpahl; S K Ghosh; U Kim; C E Elson
Journal:  Radiat Environ Biophys       Date:  1987       Impact factor: 1.925

5.  [Effect of local moderate hyperthermia in combination with N-nitroso-1,3-bis-(2-chloroethyl)urea (BCNU) and 5-fluoro-(tetrahydro-2-furyl)uracil (ftorafur) on induced autochthonous colonic cancers in the rat. 3: Polychemotherapy in combination with hyperthermia].

Authors:  E Biwer; M Lorenz; M Habs; D Schmähl
Journal:  Langenbecks Arch Chir       Date:  1984

6.  Sensitivity to thermochemotherapy of AKR lymphoma and B16 melanoma variants of malignancy.

Authors:  J Leibovici; G Klorin; M Huszar; S Hoenig; O Klein; M Michowitz; A Pinchassov
Journal:  Clin Exp Metastasis       Date:  1990 Jan-Feb       Impact factor: 5.150

7.  [Effect of moderate local hyperthermia in combination with chemotherapy with cyclophosphamide or N-nitroso- 1,3-bis(2-chloroethyl)urea(BCNU) on Yoshida sarcoma implanted in the descending colon of rats. 1. Repeated hyperthermia within 8 days and combination of chemotherapy followed by hyperthermia 24 h later].

Authors:  M Lorenz; M Habs; D Schmähl
Journal:  Langenbecks Arch Chir       Date:  1983

8.  Clinical pharmacokinetics of mitoxantrone in hyperthermic, isolated perfusion of the leg.

Authors:  J D Nagel; I Krüger; F Ghussen; U Bode
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

9.  [Effect of local moderate hyperthermia in combination with chemotherapy by N-nitroso-1,3-bis-(2-chloroethyl)urea (BCNU) on the descending colon of the rat with transplanted Yoshida sarcoma. 2. Monochemotherapy in combination with subsequent hyperthermia at various time intervals].

Authors:  M Lorenz; E Biwer; M Habs; D Schmähl
Journal:  Langenbecks Arch Chir       Date:  1984

10.  Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia.

Authors:  H Gerad; M J Egorin; M Whitacre; D A Van Echo; J Aisner
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.